Global DNA Microarray Market to Grow at a CAGR of 10.6% in the Forecast Period of 2024-2032, Aided by the Growing Awareness Regarding Genomics

The growing awareness regarding genomics is bolstering the applications of DNA microarrays, hence augmenting the market growth. With the increasing biomedical research and development (R&D) activities, the use of DNA microarrays for mutation detection, gene expression profiling, gene discovery, and mutation discovery is surging. Technological advancements and innovations in DNA microarrays for simultaneous detection of RNA and DNA sequences are likely to aid the market.

In addition, the rising demand for DNA microarrays in genotyping, gene expression profiling, and DNA sequencing is positively impacting the market growth. As the requirement for precise molecular diagnosis owing to the rising prevalence of genetically complex diseases is increasing, the market is likely to witness a healthy growth. The increasing demand for DNA microarrays in oncological applications is anticipated to provide further impetus to the market in the forecast period.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Agilent Technologies (NYSE: A), one of the leading companies in the market, introduced three new microarrays for postnatal and prenatal research in March 2020. The Agilent GenetiSure Cyto microarrays include clinically relevant and updated content from respected databases. The microarrays provide high-resolution detection of copy-neutral loss of heterozygosity and copy number variations associated with neuropsychiatric disorders, congenital anomalies, intellectual disability, and unexplained dysmorphic features in constitutional DNA samples. The sequencing allows easy discovery of new gene-disease associations, while evolving databases are rapidly including such discoveries.

Moreover, the microarrays feature a targeted design covering more than 3600 genes and provide computability with various clinically relevant samples. This makes the microarrays ideal for enhancing or upgrading testing requirements in cytogenic laboratories.

Market Analysis by Type, Product Outlook, End User, Application, and Region:

• The market, on the basis of type, can be divided into complementary DNA microarrays and oligonucleotide DNA microarrays.

• Based on product outlook, the market can be divided into consumables, software and services, and instruments.

• The major end-users of DNA microarray include hospitals and clinics, academic and research institutes, biotechnology and pharmaceutical industries, and diagnostic centres, among others.

• Microarray finds applications in transcription factor binding analysis, genotyping, and gene expression analysis, among others.

• The regional markets for DNA microarray include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The increasing use of DNA microarray in various applications such as proteomics, cancer detection, gene expression, and disease monitoring, among others, is driving the market growth.

• The market is being driven by advancements in DNA microarrays and the increasing investments in research activities to develop new DNA microarrays.

• The rising awareness regarding the utilisation of DNA microarrays in various applications is bolstering the market growth.

• The growing cases of cancer and various other disorders are increasing the utilisation of DNA microarrays, hence fuelling the market growth.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for DNA microarray for the periods (2018-2023) and (2024-2032).

• The report also offers the historical (2018-2023) and forecast (2024-2032) markets for the types, products outlook, end users, applications, and major regions of DNA microarray.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global DNA microarray market are Illumina, Inc., Thermo Fisher Scientific Inc, Agilent Technologies, Inc, Arrayit Corporation, Savyon Diagnostics, and SCIENION GmbH, among others. The comprehensive repo rt by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.